Frontiers in Genetics (Apr 2019)

Role of DNA Methylation Profile in Diagnosing Astroblastoma: A Case Report and Literature Review

  • Giuseppe Petruzzellis,
  • Iside Alessi,
  • Giovanna Stefania Colafati,
  • Francesca Diomedi-Camassei,
  • Andrea Ciolfi,
  • Lucia Pedace,
  • Antonella Cacchione,
  • Andrea Carai,
  • Marco Tartaglia,
  • Angela Mastronuzzi,
  • Evelina Miele

DOI
https://doi.org/10.3389/fgene.2019.00391
Journal volume & issue
Vol. 10

Abstract

Read online

Astroblastoma is a rare tumor of the central nervous system (CNS) with uncertain clinical behavior. Recently, DNA methylation profiling has been shown to provide a highly robust and reproducible approach for the classification of all CNS tumors across different age groups. By using DNA methylation profiling, a subset of CNS high-grade tumors with astroblastoma-like morphology characterized by the meningioma 1 gene (MN1) rearrangements, has been identified; they were termed “CNS high-grade neuroepithelial tumors with MN1 alteration” (CNS-HGNET-MN1). Here, we describe a case of CNS-HGNET-MN1 diagnosed by DNA methylation profiling, using Illumina Infinium HumanMethylationEPIC BeadChip (EPIC), that offers the opportunity to conduct a brief literature review. The patient presented with an episode of partial seizures involving the right hemisoma. A gross total resection was performed. No other treatment was proposed in light of the histological and molecular findings. After 21 months, the patient is disease-free in good clinical conditions. Also in view of this case, we recommend DNA-methylation profiling as an important tool for diagnosis and more effective patient stratification and management.

Keywords